The concerns of the FDA are there for MSB to provide their responses. I feel confident that SI and the team would have been anticipating these questions. You do not prepare a commercial team readying for approval if you have not dotted your “i’s”or crossed your “t’s”.
FDA does not just approve without putting forward any concerns, which is up to the MSB to provide clarity which you would expect the team would have been preparing to do!
GLTAH.
- Forums
- ASX - By Stock
- Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
The concerns of the FDA are there for MSB to provide their...
-
- There are more pages in this discussion • 371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.0¢ |
Change
0.030(3.13%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | $1.03 | 96.5¢ | $4.704M | 4.708M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 274051 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 1.000 |
5 | 23430 | 0.990 |
4 | 52000 | 0.985 |
3 | 6800 | 0.980 |
2 | 12101 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 15867 | 1 |
0.990 | 25 | 1 |
1.000 | 50677 | 3 |
1.005 | 57507 | 4 |
1.010 | 59403 | 3 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online